Skip to main content

Table 2 Prevalence of diagnoses

From: The diagnostic yield of the first episode of a periodic health evaluation: a descriptive epidemiology study

Categories Prevalence, n (%)
N = 491
No. Not Patient Prompted USPSTF
Recommendationsfor Screening
ENDOCRINE
Adrenal adenoma 2 (0.4) 2 NR
Diabetes mellitus Type 2 3 (0.6) 3 B*
Dyslipidemia 40 (8.2) 40 A**
Chronic fatigue 1 (0.2) 1 NR
Hyperparathyroidism 6 (1.2) 6 NR
Hyperthyroidism 2 (0.4) 2 I
Elevated lipoprotein (a) 12 (2.4) 12 NR
Metabolic syndrome 6 (1.2) 6 NR
   Obesity 95 (19.4) 88 B
   Class I 72 67  
   Class II 13 12  
   Class III 10 9  
Osteoporosis 9 (1.8) 8 B
Thyroid nodule 4 (0.8) 2 I
Hashimoto’s thyroiditis 1 (0.2) 1 I
Thyrotoxicosis 1 (0.2) 1 I
Vertebral compression fracture 2 (0.4) 2 NR
TOTAL 184 (37.4) 174  
MALIGNANCY
Non-melanoma skin 8 (1.6) 8 I
Melanoma 7 (1.4) 4 I
Prostate cancer 4 (0.8) 4 D
Renal cell carcinoma 1 (0.2) 1 NR
Pancreatic cancer 1 (0.2) 0 D
TOTAL 21 (4.2) 17  
PRE-MALIGNANT
Colon polyp (large, multiple, tubulovillous+) 5 (1.0) 5 A
PSA elevation 6 (1.2) 6 D
Night sweats 2 (0.4) 0 NR
TOTAL 13 (2.6) 11  
CARDIOVASCULAR
Aortic aneurysm, thoracic 1 (0.2) 1 NR
Aortic aneurysm, abdominal 1 (0.2) 1 B
Aortic dilatation (any area) 2 (0.4) 2 NR
Moderate aortic stenosis 1 (0.2) 1 NR
Aortic valve regurgitation 2 (0.4) 2 NR
Bicuspid aortic valve 1 (0.2) 1 NR
CAD, stable 3 (0.6) 3 D
CAD, unstable 1 (0.2) 0 NR
Chest pain 4 (0.8) 3 NR
LVH 2 (0.4) 2 NR
Patent foramen ovale 1 (0.2) 1 NR
Abnormal stress test 2 (0.4) 2 D, I***
Congestive heart failure 1 (0.2) 0 NR
Peripheral artery disease 1 (0.2) 0 D
TOTAL 23 (4.6) 19  
GASTROENTEROLOGY
Barrett’s esophagus 1 (0.2) 1 NR
Crohn’s disease 1 (0.2) 1 NR
Diverticulitis 4 (0.8) 3 NR
Diverticulosis 1 (0.2) 1 NR
Esophagitis 6 (1.2) 5 NR
Helicobacter pylori 4 (0.8) 3 NR
Hemochromatosis 1 (0.2) 1 D
Hepatitis C 1 (0.2) 1 D
Splenomegaly 2 (0.4) 2 NR
Steatohepatitis 8 (1.6) 8 NR
Mesenteric abscess 1 (0.2) 0 NR
Hematochezia 2 (0.4) 0 NR
TOTAL 32 (6.4) 25  
NEUROLOGY
Cerebral infarction 1 (0.2) 0 NR
Lumbar stenosis 1 (0.2) 1 NR
Neuropathy 6 (1.2) 2 NR
Paresthesia 12 (2.4) 4 NR
Pituitary adenoma 1 (0.2) 1 NR
Seizure 1 (0.2) 1 NR
Syringomyelia 1 (0.2) 1 NR
Spinal syrinx 1 (0.2) 1 NR
Gliomatosis cerebri 1 (0.2) 0 NR
Transient ischemic attack 1 (0.2) 0 NR
TOTAL 26 (5.2) 11  
PULMONARY
COPD 3 (0.6) 3 D
Obstructive sleep apnea 24 (4.9) 11 NR
Pleural effusion 1 (0.2) 1 I
Pleural thickening 1 (0.2) 1 I
Pneumonitis 2 (0.4) 2 NR
Upper airway resistance 1 (0.2) 1 NR
Asthma 1 (0.2) 0 NR
LTBI 1 (0.2) 1 NR
TOTAL 34 (6.9) 20  
NEPHROLOGY
IGA nephropathy 1 (0.2) 1 NR
Medullary sponge kidney 1 (0.2) 1 NR
Nephrolithiasis 3 (0.6) 2 NR
Polycystic kidney disease 2 (0.4) 2 NR
Prerenal azotemia 1 (0.2) 1 NR
Renal insufficiency 3 (0.6) 3 NR
TOTAL 11 (2.2) 10  
OPHTHALMOLOGY
Macular degeneration 3 (0.6) 3 NR
Glaucoma 4 (0.8) 4 I
Diabetic retinopathy 1 (0.2) 1 NR
TOTAL 8 (1.6) 8  
PSYCHIATRIC
Depression 9 (1.8) 1 B
Eating disorder 1 (0.2) 1 NR
Adjustment disorder 2 (0.4) 0 NR
Anxiety 8 (1.6) 1 NR
TOTAL 20 (4.0) 3  
HEALTH HABITS
Alcohol abuse 5 (1.0) 1 B
Nicotine dependency 43 (8.8) 2 A
TOTAL 48 (9.8) 3  
OTHER
Hearing loss (severe/asymmetric) 5 (1.0) 3 NR
Seronegative spondyloarthropathy 1 (0.2) 0 NR
Infertility 1 (0.2) 0 NR
Otitis media 1 (0.2) 0 NR
TOTAL 8 (1.6) 3  
TOTAL 428 (87.0) 304  
  1. Abbreviations: PSA, prostatic surface antigen; CAD, coronary artery disease; LVH, left ventricular hypertrophy; LTBI, Latent Tuberculosis Infection; COPD, chronic obstructive pulmonary disease; USPSTF, United States Preventive Services Task Force.
  2. Recommendations for average risk patient are considered Grade A- Strongly recommended; Grade B- Recommended; Grade C- No recommendation; Grade d- Recommend against routine use; Grade I- Insufficient evidence to recommend for or against the intervention; NR- No recommendation available.
  3. *Screen in individuals with hypertension, 2 out of 3 individuals met this criteria.
  4. **Screen for men age ±35 and women age ±45.
  5. ***D for adults with low risk; I for adults with increased risk for coronary heart disease. ^ elevated PSA did not result in diagnosis of prostate cancer